Cargando…
Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer
BACKGROUND: Extracellular vesicles (EVs) and their mimics from mesenchymal stem cells (MSCs) are promising drug carriers to improve cancer treatment, but their application is hindered by donor variations and expansion limitations of conventional tissue-derived MSCs. To circumvent these issues, we ma...
Autores principales: | Zhao, Qingguo, Hai, Bo, Kelly, Jack, Wu, Samuel, Liu, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792192/ https://www.ncbi.nlm.nih.gov/pubmed/33413659 http://dx.doi.org/10.1186/s13287-020-02097-5 |
Ejemplares similares
-
Inhibitory Effects of Extracellular Vesicles from iPS-Cell-Derived Mesenchymal Stem Cells on the Onset of Sialadenitis in Sjögren’s Syndrome Are Mediated by Immunomodulatory Splenocytes and Improved by Inhibiting miR-125b
por: Zhao, Qingguo, et al.
Publicado: (2023) -
Purified Mesenchymal Stem Cells Are an Efficient Source for iPS Cell Induction
por: Niibe, Kunimichi, et al.
Publicado: (2011) -
Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014) -
Understanding the mysteries of iPS cells
por: Cohen, Justin Brent, et al.
Publicado: (2009) -
iPS Cells—The Triumphs and Tribulations
por: Sharma, Riddhi
Publicado: (2016)